Journal profile · Medicine-Public Health, Environmental and Occupational Health
Journal of Virus Eradication
ISSN 2055-6640 · eISSN 2055-6659 · Elsevier · ENGLAND
Journal of Virus Eradication: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.71; fully open access; APC about USD 3,010; median 68 days to acceptance (51 articles, last 24 months); 35 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Virus Eradication is published by Elsevier and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are HIV Research and Treatment, HIV/AIDS Research and Interventions and HIV/AIDS drug development and treatment, together about 48.6% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Virus Eradication aims to provide a specialist, open-access forum to publish work in the rapidly developing field of virus eradication. The Journal covers all human viruses, in the context of new therapeutic strategies, as well as societal eradication of viral infections with preventive interventions.The Journal is aimed at the international community involved in the prevention and management of viral infections. It provides an academic forum for the publication of original research into viral reservoirs, viral persistence and virus eradication and ultimately development of cures. All submissions are peer reviewed by experts who work at major international centers of excellence.The Journal not only publishes original research, but provides an opportunity for opinions, reviews, case studies and comments on the published literature. It focusses on evidence-based medicine as the major thrust in the successful management of viral infections. The Journal encompasses virological, immunological, epidemiological, modelling, pharmacological, pre-clinical and in vitro, as well as clinical, data including but not limited to drugs, immunotherapy and gene therapy. It is an important source of information on the development of vaccine programs and preventative measures aimed at virus eradication.The Journal has an international Editorial Board comprising of leading experts in the field of innovative research and development of therapies for viral diseases. The Editorial Board is supported by an international Editorial Panel. The Editorial Board and Editorial Panel are involved in the peer-review of papers submitted for publication.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Public Health, Environmental and Occupational Health
Editor-in-chief Feng LiPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 20, United Kingdom 15, France 9, Italy 4, Belgium 3 (64 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- HIV Research and TreatmentImmunology and Microbiology26.2%
- HIV/AIDS Research and InterventionsMedicine12.1%
- HIV/AIDS drug development and treatmentMedicine10.2%
- Hepatitis C virus researchMedicine7.4%
- HIV-related health complications and treatmentsMedicine6.6%
- Immune Cell Function and InteractionImmunology and Microbiology5.3%
- Hepatitis B Virus StudiesMedicine4.1%
- Cytomegalovirus and herpesvirus researchMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Virology | Zone 3 |
| Minor | Immunology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Virology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Virology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.71LetPub ·
- Impact factor (publisher)
- 2.8Publisher website ·
- CiteScore 2026-06
- 3.6LetPub ·
- CiteScore (publisher)
- 3.6Publisher website ·
- SJR 2026-06
- 0.62LetPub ·
- SNIP 2026-06
- 0.57LetPub ·
- h-index
- 43OpenAlex ·
- i10-index
- 191OpenAlex ·
- 2-year mean citedness
- 0.66OpenAlex ·
- Self-citation rate
- 3.6%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 29LetPub ·
Articles by year OpenAlex count · 1,872 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 16 | 16 | 2 |
| 2025 | 35 | 35 | 39 |
| 2024 | 188 | 188 | 116 |
| 2023 | 45 | 45 | 267 |
| 2022 | 238 | 238 | 296 |
| 2021 | 31 | 31 | 309 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
68 daysMedian, submission to acceptance · P25–P75 38 days – 91 days
- Acceptance to online
- median 3 days (51 articles)
- Submission to online
- median 71 days
- Sample
- 51 articles with submission and acceptance dates (53 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 39 weeksLetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- First decision after review
- 34 daysPublisher website ·
- Submission to acceptance
- 73 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,010 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,950 / EUR 2,760 / GBP 2,360 / JPY 365,890 | — | — | |
| LetPub | USD 2,260 | Yes | — | |
| Publisher website | USD 2,900 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 3,500 words
- Reference style
- Numbered, in order of citation
- Cover letter
- Required
Article types accepted11
- case studiesThe Journal publishes a variety of papers: Original research, Reviews, Viewpoints, Conference reports, Letters to the editor and Case studies.Length not stated
- case studyThe Journal publishes a variety of papers: Original research, Reviews, Viewpoints, Conference reports, Letters to the editor and Case studies.Original research …Length not stated
- conference reportThe Journal publishes a variety of papers: Original research, Reviews, Viewpoints, Conference reports, Letters to the editor and Case studies.Original research …Length not stated
- conference reportsThe Journal publishes a variety of papers: Original research, Reviews, Viewpoints, Conference reports, Letters to the editor and Case studies.Length not stated
- letterThe Journal publishes a variety of papers: Original research, Reviews, Viewpoints, Conference reports, Letters to the editor and Case studies.Original research …Length not stated
- letters to the editorThe Journal publishes a variety of papers: Original research, Reviews, Viewpoints, Conference reports, Letters to the editor and Case studies.Original research …Length not stated
- original researchThe Journal publishes a variety of papers: Original research, Reviews, Viewpoints, Conference reports, Letters to the editor and Case studies.Original research …Length not stated
- reviewThe Journal publishes a variety of papers: Original research, Reviews, Viewpoints, Conference reports, Letters to the editor and Case studies.Original research …Length not stated
- reviewsThe Journal publishes a variety of papers: Original research, Reviews, Viewpoints, Conference reports, Letters to the editor and Case studies.Length not stated
- viewpointThe Journal publishes a variety of papers: Original research, Reviews, Viewpoints, Conference reports, Letters to the editor and Case studies.Original research …Length not stated
- viewpointsThe Journal publishes a variety of papers: Original research, Reviews, Viewpoints, Conference reports, Letters to the editor and Case studies.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Elsevier Publishing Ethics Policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Open access journal Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed; free preprint posting service on SSRN Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 2055-6640
- Electronic ISSN
- 2055-6659
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Virus Eradication
What CAS zone is Journal of Virus Eradication in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Virus Eradication is in Zone 3 of Medicine, and in Zone 3 of the minor category Virology / Immunology / Infectious Diseases. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Virus Eradication?
The latest impact factor listed by LetPub is 2.71; CiteScore 3.6, h-index 43.
How long does peer review take at Journal of Virus Eradication?
Based on the dates recorded on 51 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 68 days (interquartile range 38–91 days); authors report an average review time of about 39 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Virus Eradication?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 3,500 words; Reference style: Numbered, in order of citation; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Virus Eradication based?
Of the 64 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (20), United Kingdom (15) and France (9). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Virus Eradication?
According to LetPub and DOAJ records, Journal of Virus Eradication is indexed in SCIE, Scopus and DOAJ.
Is Journal of Virus Eradication open access, and what is the APC?
Journal of Virus Eradication is a fully open-access journal. APC about USD 3,010.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .